The True Side Effects of Mounjaro: What the Evidence Shows

Which side effects do most people on Mounjaro actually experience?

The short answer is: gut-related ones. Tirzepatide activates two receptors (GIP and GLP-1) that are involved in appetite signalling and gastric emptying. Slowing down how quickly the stomach empties is part of why the medicine reduces appetite, but it is also why nausea tops the list of reported effects. In the SURMOUNT-1 clinical trial, which followed thousands of adults over 72 weeks, the most frequent side effects were nausea, diarrhoea, vomiting, constipation, indigestion, and burping. Fatigue, headache, dizziness, and injection-site reactions (redness, bruising or mild discomfort where the pen is used) were also reported. The early weeks of Mounjaro tend to be the most challenging because the body is encountering tirzepatide for the first time at the starter dose.

The pattern matters: side effects tend to cluster around two moments, starting treatment and stepping up to a higher dose. Between those moments, many people find their tolerance improves considerably. Rotating injection sites between the abdomen, thigh, and upper arm can reduce localised skin reactions. For a full itemised breakdown of Mounjaro side effects by frequency category, the Mounjaro Summary of Product Characteristics on the eMC is the definitive reference.

Do the side effects get better, or do they stay the same throughout treatment?

For most people, they ease. The GI effects that feel prominent at 2.5mg or immediately after a dose increase typically reduce within a few days to around two weeks as the body adjusts. Some people experience very few side effects from the outset; others have a rougher first fortnight at each new dose level. Neither experience is unusual.

A few practical things tend to help: eating smaller portions and avoiding very fatty or rich meals reduces nausea; staying well hydrated matters especially if diarrhoea or vomiting occurs; slowing down the pace of eating is something many people find useful once appetite has changed. These are not medical instructions, your prescriber and the Patient Information Leaflet are the right source of personalised guidance. If you want to understand each side effect of Mounjaro and what typically triggers it, that page walks through the individual symptoms in detail. Adjusting the pace of titration is sometimes the answer, and that is a clinical decision. You can read more about the five most commonly reported Mounjaro effects and how people typically manage them.

When should you get urgent medical help?

Some symptoms require prompt attention and should not be waited out. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis in people using GLP-1 medicines: if you develop severe, persistent stomach pain that spreads to the back (with or without vomiting) stop treatment and seek medical help the same day. Do not assume it is ordinary nausea. Gallbladder problems (severe pain in the upper right abdomen, sometimes with fever or jaundice) are another reason for urgent assessment.

Seek help promptly if you experience signs of a serious allergic reaction: swelling of the face, lips, tongue or throat, difficulty breathing, or a widespread rash. If severe vomiting or diarrhoea leads to dehydration (signs include very dark urine, dizziness on standing, or inability to keep fluids down) that too warrants the same day attention. Anyone with a history of diabetic eye disease should be aware that rapid changes in blood sugar (even improvement) can sometimes affect the retina; report any sudden change in vision. Thoughts of self-harm or low mood that feel new or worsening should be reported to a clinician without delay.

This list is a guide, not a complete replacement for the Patient Information Leaflet. If something feels wrong and you are unsure, contacting your prescriber or calling NHS 111 is always the right call. Suspected side effects (including ones you are uncertain about) can be reported to the MHRA through the Yellow Card scheme, which helps regulators monitor safety in real-world use. You can also reach the nume team seven days a week if you have aftercare questions.

How does a prescriber weigh up side-effect risk before recommending Mounjaro?

Prescribing any medicine involves weighing likely benefit against likely risk for a specific person, and that is exactly why Mounjaro requires a prescription following a proper clinical assessment. A prescriber looks at your medical history, current medicines, and any conditions that would change the risk profile. Certain situations (a personal or close family history of medullary thyroid carcinoma or MEN2, a previous episode of pancreatitis, or specific gastrointestinal conditions) require careful consideration or rule the medicine out. Pregnancy, breastfeeding, and planning to conceive are contraindications. The medicine is not licensed for under-18s.

Women using oral contraceptives starting Mounjaro are advised to use an additional non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced. The NHS England guidance on weight-management injections covers this and the advice around HRT and surgery. At nume, a GPhC-registered Independent Prescriber reads every consultation personally before any treatment is approved, side-effect risk forms part of that review. If you want to understand whether Mounjaro is suitable given your own circumstances, a free consultation with our prescribers is the right starting point. You can also explore the full Mounjaro overview or browse the FAQs for more on how the service works.